Peptides for T cell stimulation
Products - Collection of peptides
Please use filters "Category" and "Subcategory" to quickly select your product from the list below:
| Product | Contents | Cat.no | Price | Order | |||
|---|---|---|---|---|---|---|---|
| CMV pp65 peptide NLVPMVATV (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7001-901 | USD 80.00 | ||||
|
CMV pp65 peptide NLVPMVATV (HLA-A0201) for stimulation of T-cells. Single peptide (NLVPMVATV) for stimulation of human CMV-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| EBV BMLF-1 peptide GLCTLVAML (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7002-901 | USD 80.00 | ||||
|
EBV peptide GLCTLVAML (HLA-A*0201) for stimulation of T-cells. Single peptide (GLCTLVAML) for stimulation of human EBV BMLF-1(280-288) CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| Influenza M peptide GILGFVFTL (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7003-901 | USD 80.00 | ||||
|
Influenza M peptide GILGFVFTL (HLA-A*0201) for stimulation of T-cells. Single peptide (GILGFVFTL) for stimulation of human Influenza M1-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| HIV gag peptide SLYNTVATL (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7004-901 | |||||
|
HIV gag peptide SLYNTVATL (HLA-A*0201) for stimulation of T-cells. Single peptide (SLYNTVATL) for stimulation of human HIV gag-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| HIV pol peptide ILKEPVHGV (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7005-901 | USD 80.00 | ||||
|
HIV pol peptide ILKEPVHGV (HLA-A*0201) for stimulation of T-cells. Single peptide ( ILKEPVHGV) for stimulation of human HIV pol-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| HBV core peptide FLPSDFFPSV (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7006-901 | |||||
|
HBV core peptide FLPSDFFPSV (HLA-A*0201) for stimulation of T-cells. Single peptide (FLPSDFFPSV) for stimulation of human HBV core-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| MART-1 peptide ELAGIGILTV (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7007-901 | USD 80.00 | ||||
|
MART 1 peptide ELAGIGILTV (HLA-A*0201) for stimulation of T-cells. Single peptide (ELAGIGILTV) for stimulation of human MART 1-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| HER-2/neu peptide KIFGSLAFL (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7008-901 | |||||
|
Her-2/neu peptide KIFGSLAFL (HLA-A*0201) for stimulation of T-cells. Single peptide (KIFGSLAFL) for stimulation of human Her-2/neu-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| HER-2/neu peptide RLLQETELV (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7009-901 | |||||
|
Her-2/neu peptide RLLQETELV (HLA-A*0201) for stimulation of T-cells. Single peptide (RLLQETELV) for stimulation of human Her-2/neu-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| gp100 peptide I MDQVPFSV (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7010-901 | |||||
|
Gp 100 peptide IMDQVPFSV (HLA-A*0201) for stimulation of T-cells. Single peptide (IMDQVPFSV) for stimulation of human Gp 100-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| gp100 peptide ITDQVPFSV (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7011-901 | |||||
|
Gp 100 peptide ITDQVPFSV (HLA-A*0201) for stimulation of T-cells. Single peptide (ITDQVPFSV) for stimulation of human Gp 100-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
| Tyrosinase peptide YMDGTMSQV (HLA-A*0201) for stimulation of T-cells | 1 mg | 6-7012-901 | |||||
|
Tyrosinase peptide YMDGTMSQV (HLA-A*0201) for stimulation of T-cells. Single peptide (YMDGTMSQV) for stimulation of human Gp 100-specific CD8+ T-cells. The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Lyophilized powder. Purity > 80 %, endotoxin free. |
|||||||
